semaglutide vs tirzepatide brand names vs. for Weight Loss Weight Loss Medications that Work

No single compound addresses all of these simultaneously

GLP-1- based treatments for T2DM, such as GLP-1 receptor agonists, dual and triple agonists that activate GLP-1R, GIPR, and glucagon receptors, and dipeptidyl peptidase-4 (DPP-4) inhibitors have been reviewed here

Beyond GLP-1: efficacy and safety of dual and triple incretin agonists in personalised type 2 diabetes care a systematic review and network meta-analysis

In fact, in a recent study published in The New England Journal of Medicine, participants who took Semaglutide lost an average of 15% of their body weight over a period of 68 weeks

As expected, both drugs induced a dose-responsive suppression in food intake that scaled with escalating doses